-
UK Agency Urges Asbestos Training to Protect Against Mesothelioma
The United Kingdom has been hard hit by malignant mesothelioma, the rare and fatal form of cancer cause by exposure to asbestos. The nation has a significant amount of buildings that are contaminated with the carcinogenic material, and as a result tradesmen and women continue to be put at risk, despite the fact that the
-
Roofer’s Widow Defeats Asbestos Company’s Bid to Escape Mesothelioma Lawsuit
Despite asbestos being an acknowledged carcinogen, companies whose products contain the toxic material continue to fight lawsuits filed by mesothelioma victims and others they’ve injured. Their primary method of argument is to deny both that asbestos victims actually used their product, and that the asbestos in their products was the proximate cause of their illness.
-
Israeli Blood Test Could Confirm Mesothelioma in Hours
An Israeli company has developed a new type of liquid biopsy that could confirm a diagnosis of malignant mesothelioma in a matter of hours. Much of the challenge of treating mesothelioma lies in the fact that it is most often diagnosed when it is very far advanced, and the promise of a fast and simple blood
-
Study Suggests Low-Dose CT Screening For Those At Risk for Mesothelioma
Construction workers, factory and shipyard workers, veterans and untold numbers of others are at risk for malignant mesothelioma as a result of having been exposed to asbestos. Because the rare and deadly form of cancer has such a long latency period, these men and women are forced to live with a cloud of anxiety, worrying
-
Barber Seeks Justice After His Wife Dies of Malignant Mesothelioma
A lawsuit currently making its way through the New York City Asbestos Litigation courts is pitting a man and his daughter against the companies that they say caused their wife and mother to die of malignant mesothelioma. The man, Eddie Germain, had spent decades working as a barber, and he and his daughter Mildred are
-
Initial Results from Mesothelioma Clinical Trial Show Unexpectedly Positive Results
A press release issued by the immune-oncology company Targovax ASA is inspiring hope in patients diagnosed with malignant mesothelioma. The company revealed that initial clinical results of combining their ONCOS-102 cancer virus with standard chemotherapy provided patients with significantly improved progression-free survival and disease control.
-
One-Sentence Notice from Pennsylvania Supreme Court Permits Mesothelioma Case to Continue
It has been almost five years since Leon Franklin Lamson, Jr. died of malignant mesothelioma, but his family has continued fighting for justice on his behalf, and this week they won a significant decision when the Pennsylvania Supreme Court rejected the arguments made by asbestos companies and refused to disturb an earlier court decision allowing
-
Mesothelioma Fears Drive $25 Million Asbestos Lawsuit Against City of San Diego
A contract engineer has filed a $25 million lawsuit against the city of San Diego, accusing his former employer of knowingly exposing hundreds of workers to the risk of malignant mesothelioma and other diseases and lying about the presence of asbestos in a leased high rise that it was remodeling.
-
Mesothelioma Victim’s Case Against General Electric Allowed to Continue
When Fidel Rivera’s began working as an electrician’s apprentice at the age of 18, he never dreamed that it would lead to a fatal diagnosis of malignant pleural mesothelioma. He died soon after that diagnosis, but not before he could file a lawsuit against General Electric, the company that manufactured the asbestos-contaminated products that caused
-
UK Mesothelioma Care Relies Heavily On Clinical Nurse Specialists
The United Kingdom has the highest incidence of malignant mesothelioma in the world, with roughly 2,700 people diagnosed with the rare and fatal form of the disease every year. In response to the overwhelming rate of illnesses arising from exposure to asbestos, the nation has established a treatment program that relies heavily on a network
-
Australian Study Confirms Survival Success of Combined Treatment for Peritoneal Mesothelioma
Though malignant mesothelioma is known to be a terminal illness, a recently completed Australian study has provided an optimistic conclusion for those diagnosed with the peritoneal form of the disease. According to a study of more than 1,200 patients who had both cytoreductive surgery and intraperitoneal chemotherapy, the combination of the two protocols provides long-term
-
What To do When Someone You Love Has Mesothelioma
A diagnosis of malignant mesothelioma is one of the most challenging an individual can receive. The condition is always considered fatal, and in most cases patients succumb to their illness within two years of their condition being identified. The situation is made even worse by the fact that the asbestos-related disease is entirely preventable, as
-
Nanoparticle Delivery of Chemotherapy Found To Boost Mesothelioma Survival
Malignant mesothelioma is a rare and fatal form of cancer that has proven to be frustratingly resistant to the treatment protocols that work in other forms of cancer. The disease has several factors that make it more difficult to treat, including the fact that it is rarely diagnosed before it is in its later stages.
-
Mesothelioma Experts Applaud FDA Panel’s New Asbestos Testing Recommendations
In the shadow of thousands of mesothelioma and ovarian cancer lawsuits currently pending against cosmetic talc sellers and manufacturers like Johnson & Johnson, a panel of U.S. Food and Drug Administration scientific experts have put forward new standards for testing asbestos in cosmetic products. The more strenuous testing that they are suggesting is a departure
-
North Carolina Neighbors Fear Mesothelioma After Learning of Asbestos Dumping
Residents of Davidson, North Carolina are suddenly dealing with very real concerns about malignant mesothelioma and other asbestos-related diseases after learning that their neighborhood was build adjacent to and above an asbestos dumping site. Though officials from the Division of Waste Management held a meeting to discuss long-term plans and provide assurances, few of the
-
European Mesothelioma Victims Demand Justice From Those Responsible
Though American society is frequently criticized for being overly litigious, it is also true that the U.S. justice system serves as a model for the rest of the world, and this is increasingly true when it comes to seeking justice for those diagnosed with malignant mesothelioma. In the United States, victims of asbestos exposure have
-
Occupational Medicine Study Links Cosmetic Talc to Malignant Mesothelioma
As mesothelioma lawsuits against Johnson & Johnson and other cosmetic talc companies continue being filed, a study has just been published in the official journal of the American College of Occupational and Environmental Medicine definitively linking asbestos found in these products to the illness.
-
Newly Launched Mesothelioma Trial To Test Pre-Surgical Combination Therapy
Memorial Sloan Kettering Cancer Center in New York City is a world leader in mesothelioma research, and the facility has recently launched a clinical trial that will study the efficacy of combining an immunotherapy drug with chemotherapy prior to patients undergoing surgical removal of their tumors. The hope is that patient survival time will be
-
Spanish Study Identifies Novel Drug Combination for Treatment of Mesothelioma
Researchers from the Spanish National Cancer Research Centre have just revealed successful treatment of malignant mesothelioma in laboratory animals through a novel combination of drugs that are already in use in treatment of other tumors. The scientists say that their discovery stemmed from an analysis of the rare asbestos-related form of cancer’s key molecular processes.
-
Johnson & Johnson Agrees to Rare Settlement in Midst of Mesothelioma Lawsuit
Johnson & Johnson stands accused of causing malignant mesothelioma and ovarian cancer in thousands of victims, but the company has stood firm in its arguments against all claims and has continued defending itself, even with over 17,000 cases pending. So it was notable that the company agreed to pay a California woman a settlement reportedly
